"You can lose weight faster than ever with these new drugs, but there's a big problem with them."
In recent times, weight-loss medications have become true star drugs, and new developments aim to address the issue of weight loss without muscle loss. Several pharmaceutical companies are working on a solution, particularly those that missed out in the first round of the obesity drug market, but even the market leader Novo Nordisk is not idle - as revealed in a Bloomberg article. Recently, more effective weight-loss drugs than ever before have hit the market after it was discovered that several already approved medications have this beneficial "side effect." The demand has grown so much that Novo Nordisk announced it cannot produce enough of its drug, and the company's stock has soared, making the Danish firm the largest by market capitalization in Europe. Seeing the market potential, many pharmaceutical companies have prioritized the development of weight-loss drugs, seeking solutions that allow patients to lose fat while preserving their muscle mass. When ...